Evidence map›Paper›PMID 34283323›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2022

The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study.

Josephine Storch, Carolin Fleischmann-Struzek, Norman Rose, Thomas Lehmann, Anna Mikolajetz, Srikanth Maddela, Mathias W Pletz, Christina Forstner, Ole Wichmann, Julia Neufeind and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Costs and Factors Associated with Hospitalizations Due to Severe Influenza in Catalonia (2017-2020).International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Josephine StorchInstitute of General Practice and Family Medicine, Jena University Hospital, Bachstraße 18, 07743, Jena, Germany.
Carolin Fleischmann-StruzekCenter for Sepsis Control and Care, Jena University Hospital, Bachstraße 18, 07743, Jena, Germany.ORCID https://orcid.org/0000-0002-1104-3191
Norman RoseCenter for Sepsis Control and Care, Jena University Hospital, Bachstraße 18, 07743, Jena, Germany.ORCID https://orcid.org/0000-0002-2908-205X
Thomas LehmannCenter for Clinical Studies, Jena University Hospital, Salvador-Allende-Platz 27, 07747, Jena, Germany.
Anna MikolajetzDepartment for Anesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum 1, 07740, Jena, Germany.
Srikanth MaddelaCenter for Clinical Studies, Jena University Hospital, Salvador-Allende-Platz 27, 07747, Jena, Germany.
Mathias W PletzInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
Christina ForstnerInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.ORCID https://orcid.org/0000-0002-4427-2839
Ole WichmannImmunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
Julia NeufeindImmunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
Monique VogelInstitute of General Practice and Family Medicine, Jena University Hospital, Bachstraße 18, 07743, Jena, Germany.
Konrad ReinhartCenter for Sepsis Control and Care, Jena University Hospital, Bachstraße 18, 07743, Jena, Germany.
Horst Christian VollmarInstitute of General Practice and Family Medicine, Jena University Hospital, Bachstraße 18, 07743, Jena, Germany.
Antje FreytagInstitute of General Practice and Family Medicine, Jena University Hospital, Bachstraße 18, 07743, Jena, Germany. antje.freytag@med.uni-jena.de.ORCID http://orcid.org/0000-0001-8288-2729
Vaccination 60+ Study Group
Jena University Hospital · DERobert Koch Institute · DELuther University · KR

Funding

Bundesministerium für Bildung und Forschung 03ZZ0819B
6 · The paper itself

Abstract

backgroundTo date, cost-effectiveness of influenza and pneumococcal vaccinations was assumed in several health economic modelling studies, but confirmation by real-world data is sparse. The aim of this study is to assess the effects on health care utilisation and costs in the elderly using real-world data on both, outpatient and inpatient care.

methodsRetrospective community-based cohort study with 138,877 individuals aged ≥ 60 years, insured in a large health insurance fund in Thuringia (Germany). We assessed health care utilisation and costs due to influenza- or pneumococcal-associated diseases, respiratory infections, and sepsis in 2015 and 2016. Individuals were classified into four groups according to their vaccination status from 2008 to 2016 (none, both, or either only influenza or pneumococcal vaccination). Inverse probability weighting based on 236 pre-treatment covariates was used to adjust for potential indication and healthy vaccinee bias.

resultsInfluenza vaccination appeared as cost-saving in 2016, with lower disease-related health care costs of - €178.87 [95% CI - €240.03;- €117.17] per individual (2015: - €50.02 [95% CI - €115.48;€15.44]). Cost-savings mainly resulted from hospital inpatient care, whereas higher costs occurred for outpatient care. Overall cost savings of pneumococcal vaccination were not statistically significant in both years, but disease-related outpatient care costs were lower in pneumococci-vaccinated individuals in 2015 [- €9.43; 95% CI - €17.56;- €1.30] and 2016 [- €12.93; 95% CI - €25.37;- €0.48]. Although we used complex adjustment, residual bias cannot be completely ruled out.

conclusionInfluenza and pneumococcal vaccination in the elderly can be cost-saving in selective seasons and health care divisions. As cost effects vary, interpretation of findings is partly challenging.

Indexed as

Influenza, HumanInfluenza VaccinesPneumococcal InfectionsAgedCohort StudiesCost-Benefit AnalysisHumansMiddle AgedPneumococcal VaccinesRetrospective StudiesVaccinationInfluenza VaccinesPneumococcal VaccinesClaims dataCostElderlyHealth care utilisationInfluenza vaccinationPneumococcal vaccinationReal-world data

Identifiers

PMID34283323
PMCPMC8882088
OpenAlexW3183139970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.